About neuroClues
neuroClues is a company based in Louvain-la-neuve (Belgium) founded in 2020 by Antoine Pouppez, Pierre Daye, and Pierre Pouget. neuroClues has raised $21.78 million across 4 funding rounds from investors including European Union, EIC Fund and Invest.BW. The company has 6 employees as of December 31, 2023. neuroClues offers products and services including neuroClues®. neuroClues operates in a competitive market with competitors including Tobii Dynavox, NovaSight, Artiria, Oculogica and RetiSpec, among others.
- Headquarter Louvain-la-neuve, Belgium
- Employees 6 as on 31 Dec, 2023
- Founders Antoine Pouppez, Pierre Daye, Pierre Pouget
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name P³lab
-
Annual Revenue
Not available
-
Net Profit
-$8.41 K (USD)98as on Dec 31, 2022
-
EBITDA
$165.61 K (USD)149as on Dec 31, 2022
-
Total Equity Funding
$21.78 M (USD)
in 4 rounds
-
Latest Funding Round
$11.57 M (USD), Series A
Apr 08, 2026
-
Investors
European Union
& 12 more
-
Employee Count
6
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of neuroClues
neuroClues offers a comprehensive portfolio of products and services, including neuroClues®.
Quantifies eye movements for neurological diagnosis and monitoring.
Funding Insights of neuroClues
neuroClues has successfully raised a total of $21.78M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $11.57 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in neuroClues
neuroClues has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Invest.BW.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Investment and financing services are provided for entrepreneurs in Walloon Brabant.
|
Locked | Locked | Locked | |
|
Early-stage venture capital funding is provided to startup founders.
|
Locked | Locked | Locked |
Investor details for neuroClues
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by neuroClues
Investment portfolio details for neuroClues
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - neuroClues
Detailed financials for neuroClues
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuroclues Comparisons
Peer comparison for neuroClues
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of neuroClues
neuroClues operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, NovaSight, Artiria, Oculogica and RetiSpec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
|
|
| Locked | Locked | Locked |
Eye-tracking solutions for vision assessment and treatment are provided.
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Eye-tracking technology is utilized to detect traumatic brain injuries.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Eye-tracking devices are developed for neurodegenerative disease monitoring.
|
Detailed competitors of neuroClues
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuroclues
Complete news archive for neuroClues
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about neuroClues
neuroClues was founded in 2020 and raised its 1st funding round 1 year after it was founded.
neuroClues is headquartered in Louvain-la-neuve, Belgium. It is registered at Louvain-la-neuve, Walloon Brabant, Belgium.
Antoine Pouppez is the current CEO of neuroClues. They have also founded this company.
neuroClues is a funded company, having raised a total of $21.78M across 4 funding rounds to date.
As of Dec 31, 2023, the latest employee count at neuroClues is 6.
Provider of eye-tracking devices for healthcare practitioners. The company has developed portable eye-tracking environment called Biomarkers in a Blink. It helps practitioners quantify their clinical exams instantly and empower clinicians with Biomarkers allowing them to identify Neurological Disorders.
neuroClues's top competitors include NovaSight, RetiSpec and Tobii Dynavox.
neuroClues offers neuroClues®.
neuroClues has 13 investors. Key investors include European Union, EIC Fund, Invest.BW, Graph Ventures, and Olivier Legrain.